XM Amerika Qoʻshma Shtatlari fuqarolariga xizmat koʻrsatmaydi.

Teleflex shares slump as hurricane impact weighs on annual revenue forecast



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-Teleflex shares slump as hurricane impact weighs on annual revenue forecast</title></head><body>

Rewrites paragraph 1 to reflect revenue forecast cut, adds comments from conference call in paragraphs 2,3,7,9

By Mariam Sunny

Oct 31 (Reuters) -Teleflex TFX.N shares dropped more than 16% on Thursday, after the surgical instrument maker cut its annual revenue forecast to reflect canceled surgeries in the current quarter and an ongoing shortage of intravenous saline fluids in the United States.

The company said it saw cancellations of some procedures early in the fourth quarter due to disruptions from recent hurricanes in the U.S.

CEO Liam Kelly said on the earnings conference call that the company expects this to be a "short term, temporary" impact to its operations.

Teleflex now expects its annual revenue to grow between 2.9% and 3.4%, down from a 3.4% to 4.4% increase expected earlier.

Production at Baxter International's BAX.N North Carolina plant, which makes 60% of the United States' supply of IV fluids, was temporarily closed late last month due to flooding caused by the Hurricane Helene.

The shortage of IV products is forcing hospitals to defer elective procedures and could hurt companies that make related medical devices, according to analysts.

Besides, Kelly said Teleflex's OEM segment, which makes instruments for other device manufacturers, saw an "unanticipated softness" in the third quarter.

The unit reported quarterly sales of $82.6 million, below estimates of $88.95 million, a consensus of four analysts compiled by LSEG showed.

Teleflex said its quarterly results were also impacted by an ongoing doctors' strike in South Korea, which it expects to linger through the remainder of the year.

Revenue for the third quarter rose 2.4% to $764.4 million, but missed estimates of $769.6 million.

Adjusted profit per share of $3.49 for the three months ended Sept. 29 topped estimates of $3.39.

The Wayne, Pennsylvania-based company also raised the lower end of its 2024 adjusted per-share profit forecast to $13.90 from $13.80 previously, while keeping the upper end at $14.20.



Reporting by Puyaan Singh and Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar

</body></html>

Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.

Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi

Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.

Riskdan ogohlantirish: Kapitalingiz risk ostida. Kredit yordamiga ega mahsulotlar hammaga ham toʻgʻri kelmasligi mumkin. Bizning Risklardan ogohlantirishimiz bilan tanishib chiqing.